BAZAAR PULSE
invest4Edu
MARKET SNAPSHOT
Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
---|---|---|---|---|---|---|---|---|---|---|---|
12 Sep 2025 | Nifty 50 |
invest4Edu
|
25114.00 |
Daily Note
|
|||||||
12 Sep 2025 | Nifty 50 |
SBI Securities
|
25114.00 |
Daily Note
|
|||||||
12 Sep 2025 | Bank Nifty |
SBI Securities
|
54809.30 |
Daily Note
|
|||||||
11 Sep 2025 | Banks |
Deven Choksey
|
Top Picks
|
Life Insurance Companies Monthly Business Update- August-2025
Deven Choksey
India’s life insurance industry saw a decline in new business premiums in August 2025, with total collections declining by 5.2% YoY to INR 309.6bn compared to INR 326.4bn in August 2024.
|
|||||||
11 Sep 2025 | World Economy and Markets |
Axis Direct
|
Daily Note
|
Daily Fundamental View:September 11, 2025
Axis Direct
Asian markets are trading mixed, after a rally on Wall Street drove stocks and bonds higher, supported by easing U.S. producer prices that strengthened expectations of a Fed rate cut next week. Nikkei is trading higher by 0.66%, while Hang Seng and Shanghai are trading lower by 1.17% and 0.38%
|
|||||||
11 Sep 2025 | Nifty 50 |
SBI Securities
|
25114.00 |
Daily Note
|
|||||||
11 Sep 2025 | Nifty 50 |
SBI Securities
|
25114.00 |
Daily Note
|
|||||||
11 Sep 2025 | Bank Nifty |
SBI Securities
|
54809.30 |
Daily Note
|
|||||||
11 Sep 2025 | Market Movement |
Ventura
|
Daily Note
|
||||||||
11 Sep 2025 | Bank Nifty |
SBI Securities
|
54809.30 |
Daily Note
|
|||||||
10 Sep 2025 | Bank Nifty |
SBI Securities
|
54809.30 |
Daily Note
|
|||||||
10 Sep 2025 | Nifty 50 |
SBI Securities
|
25114.00 |
Daily Note
|
|||||||
10 Sep 2025 | World Economy and Markets |
Axis Direct
|
Daily Note
|
||||||||
10 Sep 2025 | Bank Nifty |
SBI Securities
|
54809.30 |
Daily Note
|
|||||||
10 Sep 2025 | Market Movement |
Ventura
|
Daily Note
|
||||||||
10 Sep 2025 | Nifty 50 |
invest4Edu
|
25114.00 |
Daily Note
|
|||||||
10 Sep 2025 | Brokerage Research Reports |
Geojit BNP Paribas
|
Sell
|
DIVI' S LAB
Geojit BNP Paribas
The company's outlook remains positive due to growth drivers such as increased traction from global innovators, a healthy pipeline of RFPs, expansion of scientific and technological capabilities, and steady growth in the nutraceutical business. Management highlighted persistent pricing pressures in generics and higher cost escalation compared to custom synthesis, weighing on margins. Regulatory delays of 12-24 months for peptides, contrast media, and Kakinada approvals restricted near term revenue conversion. Divi's also faces the risk of losing business related to...
|
|||||||
10 Sep 2025 | Nifty 50 |
SBI Securities
|
25114.00 |
Daily Note
|
|||||||
09 Sep 2025 | Nifty 50 |
SBI Securities
|
25114.00 |
Daily Note
|
|||||||
09 Sep 2025 | Nifty 50 |
Deven Choksey
|
25114.00 |
Daily Note
|
|||||||
more
loading
|